|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400089455 |
|
最近更新日期: Date of Last Refreshed on: |
2024-09-09 15:15:39 |
|
注册时间: Date of Registration: |
2024-09-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
AI与护士指导的表达性写作对癌症患者心理健康影响的随机对照试验研究 |
|
Public title: |
A Randomized Controlled Trial Comparing AI-Driven Versus Nurse-Guided Expressive Writing for Psychological Well-being in Cancer Patients |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
AI与护士指导的表达性写作对癌症患者心理健康影响的随机对照试验研究 |
|
Scientific title: |
A Randomized Controlled Trial Comparing AI-Driven Versus Nurse-Guided Expressive Writing for Psychological Well-being in Cancer Patients |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
杨雪岭 |
研究负责人: |
杨雪岭 |
|
Applicant: |
Xueling Yang |
Study leader: |
Xueling Yang |
|
申请注册联系人电话: Applicant telephone: |
+86 186 6500 0250 |
研究负责人电话: Study leader's telephone: |
+86 186 6500 0250 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
yhtyxl2006@126.com |
研究负责人电子邮件: Study leader's E-mail: |
yhtyxl2006@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广州市白云区沙太南路1023号-1063号 |
研究负责人通讯地址: |
广州市白云区沙太南路1023号-1063号 |
|
Applicant address: |
No. 1023-1063, Shatai South Road, Baiyun District, Guangzhou |
Study leader's address: |
No. 1023-1063, Shatai South Road, Baiyun District, Guangzhou |
|
申请注册联系人邮政编码: Applicant postcode: |
510515 |
研究负责人邮政编码: Study leader's postcode: |
510515 |
|
申请人所在单位: |
南方医科大学 |
||
|
Applicant's institution: |
Southern Medical University |
||
|
研究负责人所在单位: |
南方医科大学 |
||
|
Affiliation of the Leader: |
Southern Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
南医伦申[2024]第14号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
南方医科大学生物医学伦理委员会 |
||
|
Name of the ethic committee: |
Biomedical Ethics Committee of Southern Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-04-01 00:00:00 |
||
|
伦理委员会联系人: |
马俊 |
||
|
Contact Name of the ethic committee: |
Jun Ma |
||
|
伦理委员会联系地址: |
南方医科大学行政楼215 |
||
|
Contact Address of the ethic committee: |
Room 215, Administration Building, Southern Medical University |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 20 6164 7452 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
majun11@smu.edu.cn |
|
研究实施负责(组长)单位: |
南方医科大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Southern Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广州市白云区沙太南路1023号-1063号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 1023-1063, Shatai South Road, Baiyun District, Guangzhou |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金(72274090);教育部人文社会科学研究项目(22YJCZH182) |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation of China (72274090); Humanities and Social Sciences of the Ministry of Education, China (22YJCZH182). |
||||||||||||||||||||||
|
Target disease: |
Cancer |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究旨在比较人工智能驱动和护士引导的表达性写作干预对癌症患者心理健康的影响。具体而言,本研究将评估两种干预模式在减轻焦虑和抑郁症状、降低对疾病进展的恐惧感以及提升心理韧性方面的效果差异。此外,本研究还将探讨患者对两种干预模式的满意度和接受程度。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aims to compare the effects of AI-driven and nurse-guided expressive writing interventions on the psychological well-being of cancer patients. Specifically, this study will evaluate the differential effectiveness of the two intervention modalities in reducing anxiety and depressive symptoms, decreasing fear of disease progression, and enhancing psychological resilience. Additionally, this study will explore patient satisfaction and acceptability of the two intervention approaches. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)年龄在18~60岁;(2)被诊断患有任何类型的癌症;(3)完成手术、化疗或放射治疗等主要治疗,并且处于恢复期,没有复发的迹象;(4)拥有足够的汉语水平,能够理解研究程序,并通过写作表达自己的想法和感受;(5)愿意并能够通过中文实时通讯软件QQ参与表达性写作干预。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) aged 18~60 years; (2) having a diagnosis of any type of cancer; (3) completion of primary treatments such as surgery, chemotherapy, or radiation therapy, and being in the recovery phase without signs of relapse; (4) possessing sufficient literacy in Chinese to understand the study’s procedures and to express their thoughts and feelings through writing; (5) willingness and ability to engage in the expressive writing interventions via QQ, a Chinese real-time communication software. |
||||||||||||||||||||||
|
排除标准: |
(1)在研究期间正在接受急性精神病治疗;(2)有严重精神疾病史,如精神分裂症或躁郁症,可能会干扰研究程序;(3)有认知障碍,妨碍知情同意或理解表达性写作说明;(4)参加其他心理治疗干预或临床试验,可能会影响本研究的结果。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) undergoing acute psychiatric treatment at the time of the study; (2) having a history of severe psychiatric disorders such as schizophrenia or bipolar disorder that could interfere with study procedures; (3) having cognitive impairments that preclude informed consent or understanding of the expressive writing instructions; (4) participation in another psychotherapy intervention or clinical trial that could potentially influence the outcomes of this study. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-04-01 00:00:00至 To 2025-04-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-09-10 00:00:00 至 To 2024-11-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机序列由一位独立于研究团队的统计学家使用专业统计软件R生成。这些软件根据预先设定的参数(三组样本量比例为 1:1:1)生成不可预测的随机数字序列,确保组间分配的随机性。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The randomization sequence was generated by a statistician independent of the research team using specialized statistical software R. The software generates an unpredictable sequence of random numbers based on pre-defined parameters (1:1:1 allocation ratio for the three groups), ensuring random group assignment. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
本研究采用单盲评估。负责收集数据和进行评估的研究人员对参与者的分组分配情况保持不知情。具体而言,所有参与者都将使用唯一的代码进行识别,而不是使用其姓名或其他可识别信息。评估人员在研究结束之前不会被告知参与者的分组分配,以确保他们在收集和分析数据时不会受到主观偏见的影响。 |
|
Blinding: |
This study employs a single-blind assessment procedure. The research staff responsible for data collection and assessments are blinded to the participants' group assignments. Specifically, all participants are identified using unique codes rather than their names or other identifiable information. The assessors remain unaware of the participants' group allocation until the conclusion of the study to prevent any potential bias during data collection and analysis. |
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
本研究的脱敏原始数据将在研究结束后 2025 年 12 月 31 日起公开共享。数据将上传至(Research Manager, ResMan)平台:http://www.clinicaltrialecrf.org |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The anonymized raw data of this study will be publicly shared after the study ends on December 31, 2025. The data will be uploaded to the (Research Manager, ResMan) platform: http://www.clinicaltrialecrf.org |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
本研究将采用病例记录表 (CRF) 和问卷星电子数据采集系统 (EDC) 相结合的方式进行数据采集和管理。 数据采集:研究者将使用纸质版 CRF 收集参与者的社会人口学信息、以及临床特征;使用EDC采集各时间点的量表评估结果。 CRF 设计符合标准化数据收集规范,并经过预测试以确保其清晰易懂。 问卷星平台将用于创建电子版问卷,并通过安全链接发送给参与者,以收集相关数据。 所有纸质 CRF 将被妥善保管于安全、上锁的文件柜中。 数据保存:问卷星平台收集的电子数据将下载并存储于南方医科大学公共卫生学院心理学系认知控制与脑健康实验室的安全服务器中。该服务器配备了防火墙、数据加密和访问控制等安全措施,以确保数据安全。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
This study will employ a combination of Case Report Forms (CRFs) and the Wenjuanxing Electronic Data Capture (EDC) system for data collection and management. Data Collection: Researchers will utilize paper-based CRFs to collect participants' sociodemographic information and clinical characteristics; use EDC collect questionnaire assessments at each time point. CRFs are designed according to standardized data collection practices and will be pre-tested to ensure clarity and ease of use. The Wenjuanxing platform will be used to create electronic questionnaires, which will be sent to participants through secure links for data collection. All paper CRFs will be stored securely in locked file cabinets. Data Storage: Electronic data collected through the Wenjuanxing platform will be downloaded and stored on a secure server located at the Cognitive Control and Brain healthy Laboratory, Department of Psychology, School of Public Health, Southern Medical University. The server is equipped with security measures such as firewalls, data encryption, and access controls to ensure data security. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |